The variation in results compared to previous studies may be due to small sample size, differences in tissue processing, the type of assay used for EGFR measurement, the cut-off values for EGFR positivity, variation in breast cancer subtypes or ethnic disparities. This evidence concerns the gene EGFR and breast cancer.